Cyclosporin treatment and nitric oxide release in human coronary arteries.
作者信息
Dinh-Xuan A T, Higenbottam T W
出版信息
Br Heart J. 1992 May;67(5):420-1. doi: 10.1136/hrt.67.5.420.
Abstract
摘要
相似文献
1
Cyclosporin treatment and nitric oxide release in human coronary arteries.环孢素治疗与人类冠状动脉中的一氧化氮释放
Br Heart J. 1992 May;67(5):420-1. doi: 10.1136/hrt.67.5.420.
2
Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries.环孢素治疗不会损害人冠状动脉中一氧化氮的释放。
Br Heart J. 1991 Sep;66(3):212-6. doi: 10.1136/hrt.66.3.212.
3
Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.环孢素A、霉酚酸酯和他克莫司用药期间大鼠心脏移植血管病发生过程中一氧化氮合酶的表达
Cardiovasc Ther. 2016 Aug;34(4):183-90. doi: 10.1111/1755-5922.12181.
4
Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.环孢素治疗可保留大鼠心脏同种异体移植中冠状动脉阻力血管的功能。
J Heart Lung Transplant. 2004 Feb;23(2):193-203. doi: 10.1016/S1053-2498(03)00113-X.
5
The effect of cyclosporine on the release of endothelium-derived relaxing factor from isolated human epicardial coronary arteries.
Transplantation. 1991 Mar;51(3):736-8.
6
Pyocyanin inhibits both nitric oxide-dependent and -independent relaxation in porcine coronary arteries.绿脓菌素可抑制猪冠状动脉中一氧化氮依赖性和非依赖性舒张。
Clin Exp Pharmacol Physiol. 2015 Feb;42(2):186-91. doi: 10.1111/1440-1681.12340.
7
Anaphylaxis of small arteries: putative role of nitric oxide and prostanoids.小动脉过敏反应：一氧化氮和前列腺素的可能作用。
Medicina (Kaunas). 2010;46(1):38-44.
8
Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin.环孢素A在实验性缺血再灌注中的心脏保护作用——内皮素介导的一氧化氮依赖性机制的证据
J Mol Cell Cardiol. 1997 Feb;29(2):535-44. doi: 10.1006/jmcc.1996.0297.
9
Exogenous hyaluronidase induces release of nitric oxide from the coronary endothelium.
J Thorac Cardiovasc Surg. 2000 Oct;120(4):707-11. doi: 10.1067/mtc.2000.108905.
10
Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries.内皮源性一氧化氮在猪冠状动脉阻力动脉中的重要性。
Am J Physiol. 1991 Jan;260(1 Pt 2):H13-20. doi: 10.1152/ajpheart.1991.260.1.H13.
本文引用的文献
1
Non-prostanoid endothelium-derived vasoactive factors.
J Int Med Res. 1989 Jul-Aug;17(4):305-15. doi: 10.1177/030006058901700401.
2
Substance P dilates epicardial coronary arteries and increases coronary blood flow in humans.P物质可使人类的心外膜冠状动脉扩张并增加冠状动脉血流量。
Circulation. 1989 Sep;80(3):475-84. doi: 10.1161/01.cir.80.3.475.
3
4
Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension.原发性高血压患者内皮依赖性血管舒张异常。
N Engl J Med. 1990 Jul 5;323(1):22-7. doi: 10.1056/NEJM199007053230105.
5
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease.慢性阻塞性肺疾病中内皮依赖性肺动脉舒张功能受损。
N Engl J Med. 1991 May 30;324(22):1539-47. doi: 10.1056/NEJM199105303242203.
6
Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries.环孢素治疗不会损害人冠状动脉中一氧化氮的释放。
Br Heart J. 1991 Sep;66(3):212-6. doi: 10.1136/hrt.66.3.212.
7
The effect of cyclosporine on the release of endothelium-derived relaxing factor from isolated human epicardial coronary arteries.
Transplantation. 1991 Mar;51(3):736-8.
8
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries.动脉粥样硬化性心外膜冠状动脉中一氧化氮的基础释放和刺激释放均较低。
Lancet. 1990 Oct 13;336(8720):897-900. doi: 10.1016/0140-6736(90)92269-n.
Zotero 插件